Investors in Padlock Therapeutics have accused Bristol Myers Squibb of reneging on payments of up to $450 million negotiated ...

Savvy plaintiffs-side attorneys are leveraging this split to avoid bringing their FLSA collective action where the employer ...

Johnson & Johnson and other pharma companies aim to change how the 340B Drug Pricing Program functions. Courts must rule if ...

When hiring job candidates to work on cell and gene therapies, companies look for more than just technical skills. Talent ...

Bristol Myers Squibb (NYSE: BMY) today announced that its Board of Directors has declared a quarterly dividend of sixty-two cents ($0.62) per share on the $0.10 par value common stock of the company.

Squibb announced that its Board of Directors has declared a quarterly dividend of 62c per share on the 10c par value common ...

Shares of Bristol Myers Squibb Co. BMY slid 1.00% to $58.12 Tuesday, on what proved to be an all-around grim trading session ...

Bristol-Myers Squibb Co. plotted to rip off investors in a 2016 acquisition through legal gamesmanship aimed at evading a ...

Bristol-Myers Squibb Company (BMY), headquartered in New York and with a market cap of $121.6 billion, is a global leader in ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

The annualized dividend paid by Bristol Myers Squibb Co. is $2.4/share, currently paid in quarterly installments, and its most recent dividend ex-date was on 10/04/2024 ...

The stock's fall snapped a two-day winning streak.